FILING ANALYSIS · WEDNESDAY, NOVEMBER 4
Zomedica Corp. ZOMDF — 8-K: Results of Operations and Financial Condition
positive
Zomedica Corp. reported record third quarter revenue of $9.9 million, up 22% year-over-year, with a net loss reduced by 48% and $41 million in liquidity, driven by sustained demand for its products and increasing adoption of diagnostic offerings.
How we read impact: we grade every directional call in the open. Impact labels are AI estimates — not investment advice. See the full disclaimer.
Get filings like this every market day
The US SEC filings, UK RNS, EU notices, and Polymarket odds that matter — scored by AI, in one email.
Subscribe free →